Merit Medical CEO Fred Lampropoulos Lays Out Aggressive Growth Strategy, Including Opportunistic M&A

Spoiler Alert: I missed a huge part of Merit Medical CEO Fred Lampropoulos’ life story when I did my research. I won’t say what it was, but you’ll hear it at the end. I’d fire my researcher if I had one, but instead I’ll just throw myself at the mercy of the Medtech Talk Podcast community. The good news, however, is that the thing that I missed – which would have removed Fred from Merit – didn’t happen, so he’s been able to build a multibillion-dollar Medtech that’s scooping up smaller players in the space. Fred’s an engaging fellow and we covered a lot of ground, including: 

• What is Merit looking for in an acquisition target?
•  How does Lampropoulos manage a publicly traded Medtech?
•  Why doesn’t Utah have more Medtech start-ups? 
•  And finally, what does Lampropoulous have to say about the spate of bad press Medtech has been getting lately?

At the Medtech Conference on May 29–30 hear from CEOs who have led their companies through an IPO and learn what they must do to thrive on the public markets, in the panel – How to Build for an IPO … and Beyond.

Panelists include:

Joe Army, President & CEO - Vapotherm
Tim Herbert, President & CEO - Inspire Medical Systems
Gerald R. Mattys, CEO - Tactile Medical